Gynesonics
Gynesonics Announces First Office-Based Sonata Treatment Procedure in the State of Texas
Sonata Treatment is a breakthrough alternative to hysterectomy & myomectomy, & can treat a wider range of fibroid types, sizes, & locations than hysteroscopic myomectomy.
Gynesonics Announces Publication of Clinical Study Analysis Demonstrating Effectiveness of the Sonata System in Treating Submucous and Large Symptomatic Uterine Fibroids
The article is an analysis of a subgroup of patients with submucous or large fibroids from two previously published multicenter prospective clinical trials (FAST-EU and SONATA) of transcervical fibroid ablation (TFA) with the Sonata System.
Gynesonics Announces Publication of CHOICES
Sonata demonstrates significant advantages in reducing procedure time, length of stay and procedure-related costs compared to myomectomy.
Gynesonics Reports Sonata System Assists Facilities Impacted by the COVID-19 Pandemic in Restarting Elective Gynecologic Procedures
Sonata integrates the first and only intrauterine ultrasound system with a proprietary advanced radiofrequency ablation device to treat symptomatic fibroids in a transcervical, incision-free, uterus-preserving manner.
Next Generation Sonata System 2.1 Receives FDA Market Clearance
The new advances in Sonata® System 2.1 include a new integrated treatment device design that enables all procedure steps to be performed on the sterile field and in the palm of the physician’s hand.
